Gentel plans to add 50 new kits to its product portfolio by the end of the year, as it transforms itself from being a services-oriented business to one that derives the bulk of its sales from products.
The collaboration covers Protein Biotechnologies' SomaPlex arrays and Gentel Bioscience's APiX View Detection Kits, which were launched this week.
Illumina's VeraCode ADME Core Panel, Aushon Biosystems' human vascular injury panels, BioServe and Protein Biotechnologies' SomaPlex reverse-phase protein microarrays
The SomaPlex Reverse Phase Protein Microarray is the first product stemming from a collaboration between the two firms, and additional arrays are planned for launch throughout 2010.
Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.
US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.
A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.
In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.